2,220
Views
27
CrossRef citations to date
0
Altmetric
Original Research

One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2–4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis

, , , , , , , , , & show all